INTRODUCTION
The intra-partum stress is well tolerated by a normal foetus but a compromised foetus can't sustain this so the potential risk of intra-partum hypoxia and subsequent hypoxic ischemic encephalopathy is common in high risk pregnancies and they need proper intra-partum monitoring. Birth asphyxia accounts for 4-9 million cases globally, out of which 1.2 million dies every year. Birth asphyxia accounts for 23% of all neonatal deaths. Intrapartum events are responsible for 8-15% of cerebral palsy, 20% of stillbirth and 10% of severe mental retardation. So labour should be monitored by an ideal method which should be non-invasive, reliable, readily available, easily interpretable, and should identify labour abnormalities. Admission cardiotocography (CTG) comprises a CTG of 20-30 minutes done at admission to Labour room. This test can identify foetus which are compromised in the early labour and needs a continuous foetal monitoring. Most RCTs were of opinion that the admission test led to more intervention with no additional benefits to newborn in low risk pregnancy. 1 In 1989 ACOG recommended that intermittent auscultation is equivalent to continuous electronic foetal monitoring in detecting intra-partum foetal compromise. Neilson The aim of our study is to predict correlation between admission CTG and perinatal outcome. They were subjected to admission CTG for 20 minutes.
METHODS
The results of the test were categorized as normal/reactive, equivocal/suspicious, and abnormal/nonreactive as per NICE guidelines (Table 2) for the interpretation of CTG tracings.
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Inclusion criteria
Women admitted in the 1st stage of labour with singleton pregnancy and a gestational age more than 196 days with high risk factors as mentioned in the table.
Patients with a normal/reactive test were monitored by intermittent auscultation for 1 minute, every 30 minutes in the first stage of labour and every 5 minutes in the second stage of labour. Those with abnormal tracings were placed on continuous CTG monitoring. Those with non-reassuring foetal heart rate, appearance of late or variable decelerations were considered non-reactive. In these patients delivery was hastened by operative or instrumental intervention depending on the stage of labour. The mode of delivery was documented in all these patients. Peri-natal outcome was assessed in terms of meconium staining, APGAR score, and SNCU admissions and rate of neonatal mortality.
RESULTS
Results of the study are depicted in tabulated form. Out of the 200 cases 164 had reactive admission test, 14 had equivocal and 22 had abnormal tracings (Table 3 ). In the reactive test group 47.5% underwent LSCS as compared to 81% in abnormal test group (Table 4) . Foetal distress occurred in 64% of cases in abnormal test (Table 5) . APGAR score at 5 min after birth <7 in 50% of abnormal test (Table 7) . Admission to SNCU was 45 % in abnormal group (Table 6 ). Whatsoever measures we took, even then there were 6 stillbirths and 4 neonatal deaths in abnormal test group. 
DISCUSSION
Amongst the different modalities of intra-partum foetal monitoring, CTG is most reliable and informative which is non-invasive also. Admission CTG is a 20 min continuous recording of foetal heart rate immediately after admission to the labour room which segregates the high risk women into normal and abnormal group, where the abnormal group is more vulnerable to adverse foetal outcome. Previous RCTs and various studies have shown that there is an increase rate of LSCS and instrumental delivery in the abnormal CTG women.
Although a Cochrane review recommends that continuous EFM be limited to high-risk pregnancies, this may not be possible in developing countries where antenatal care is inadequate with a large number of highrisk pregnancies being delivered in crowded settings and inadequate health care provider to patient ratios. 6 Gourounti et al, have done a meta-analysis of different RCTs where admission CTG was done in low risk patients and they have found that in CTG group there was increase rate of caesarean section and instrumental delivery and no neonatal benefit in terms of birth asphyxia and admission to SNCU was found. 7 In our study foetal distress was found in 64% of nonreactive cases and 29% of reactive cases as compared to Ingemarsson et al, done in low risk patients where they had foetal distress in 40% of non-reactive group and 1.4% in reactive group. 8 Das V et al, included both high risk and low risk cases in their study and found that foetal distress was 31.5 % in high risk and 18.8% in low risk of reactive category, whereas it was 54% in high risk and 1.1% in low risk in non-reactive category. 9 Sandhu et al, have done admission CTG in high risk patients where they found that foetal distress occurred in 15% of reactive group and 73% in non-reactive group. 10 High incidence of foetal distress in our study may be due to inclusion of only high risk cases which correspond with the study by Sandhu et al. In present study positive predictive value is 63% for foetal distress with low sensitivity and high specificity as compared to study of Sandhu et al whose PPV is 73%. The sensitivity, specificity, positive predictive value for 5 min APGAR score <7 in our study was 44.4%, 95%, 50% respectively (Table 8) which are corresponding with the study of Sandhu et al study (APGAR score <5). Also admission test has high specificity and low sensitivity in predicting outcomes in high risk cases which is consistent with the study of Rahman et al (specificity 95%) who have also assessed in high risk cases. 13 With regard to SNCU admission the positive predictive value in present study is 63% as compared to 33% in study by Sandhu et al. This adverse event was rare in their study in both normal as well as abnormal category so the PPV is less whereas our institution is a referral centre where the number of late referral cases are more resulting in high SNCU admissions. In our study in spite of continuous foetal monitoring there were 4 neonatal deaths in reactive and 10 in non-reactive group.
CONCLUSION
CTG is a non-invasive test to detect the current status of the foetus which is sensitive for detection of adverse foetal outcome. The only disadvantage is that the patient as well as the treating obstetrician may have a false sense of relief where admission CTG is reactive, but the status may change during the process of labour. In case of high risk pregnancies with heavy patient burden and low resource setting, admission CTG is a sensitive and specific test in predicting peri-natal outcome. However more number of systematic studies and RCTs are required to prove or disprove the fact.
